Drugmakers of insulin accused of price fixing

Reema Khrais Jan 31, 2017
HTML EMBED:
COPY

Drugmakers of insulin accused of price fixing

Reema Khrais Jan 31, 2017
HTML EMBED:
COPY

Three of the biggest makers of diabetes treatments have been accused of price fixing. A lawsuit filed this week claims that Sanofi, Novo Nordisk and Eli Lilly have been conspiring to drive up prices of insulin at the expense of their patients. Because of the high prices, the suit says some patients have been using expired insulin or starving themselves to control their blood sugar. The drug makers say the allegations have no merit. 

Click the above audio player to hear the full story. 

We’re here to help you navigate this changed world and economy.

Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.

In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.

Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.

$5/month special ending soon!

Don’t wait: there’s less than 24 hours left to get (almost) any Marketplace thank-you gift.